Covered recipient · General Payments record
MICHAEL DROBBIN
Allopathic & Osteopathic Physicians Otolaryngology
General Payments · PY2018–2022
$3,754.74
- Reported across 50 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2022 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $284.44 | 9 |
| Education | $98.99 | 1 |
By paying entity
PY2022 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Acclarent, Inc | $122.38 | 1 |
| SANOFI-AVENTIS U.S. LLC | $98.99 | 1 |
| GENZYME CORPORATION | $85.66 | 4 |
| GlaxoSmithKline, LLC. | $30.59 | 2 |
| OptiNose US, Inc. | $23.07 | 1 |
| PFIZER INC. | $22.74 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2022 (10)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Acclarent, Inc | $122.38 | 05/12/2022 | Food and Beverage | Undisputed | 01/23/2026 | 886988011 | CMS |
| GENZYME CORPORATION | $14.77 | 03/29/2022 | Food and Beverage | Undisputed | 01/23/2026 | 938928395 | CMS |
| GENZYME CORPORATION | $28.12 | 05/24/2022 | Food and Beverage | Undisputed | 01/23/2026 | 938928411 | CMS |
| GENZYME CORPORATION | $22.86 | 06/21/2022 | Food and Beverage | Undisputed | 01/23/2026 | 938928415 | CMS |
| GENZYME CORPORATION | $19.91 | 07/19/2022 | Food and Beverage | Undisputed | 01/23/2026 | 938928419 | CMS |
| GlaxoSmithKline, LLC. | $14.82 | 04/01/2022 | Food and Beverage | Undisputed | 01/23/2026 | 944938825 | CMS |
| GlaxoSmithKline, LLC. | $15.77 | 06/03/2022 | Food and Beverage | Undisputed | 01/23/2026 | 944938827 | CMS |
| OptiNose US, Inc. | $23.07 | 06/01/2022 | Food and Beverage | Undisputed | 01/23/2026 | 928136259 | CMS |
| PFIZER INC. | $22.74 | 05/02/2022 | Food and Beverage | Undisputed | 01/23/2026 | 949131079 | CMS |
| SANOFI-AVENTIS U.S. LLC | $98.99 | 06/21/2022 | Education | Undisputed | 01/23/2026 | 938928413 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022
- Generated from
- OP_DTL_GNRL_PGYR2022_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.